Glaukos Corporation (GKOS)

Healthcare
$140.22▼ 3.45 (2.40%)
Real-time prices · US Markets
📅
Next earnings: Jul 29
Neutral
5.8 / 10
Clean balance sheet with low leverage (0.2× debt-to-equity).
currently unprofitable (-34% margin).
Quality
1.1
Health
9.2
Growth
7.4
Valuation
4.2
Sentiment
8.9
Analyst Target
$147.58
▲ +5.3% from current

Price Chart

Fundamentals

Trailing P/E
price-to-earnings
Forward P/E
293.1×
next 12 months est.
Market Cap
$8.2B
market capitalization
Div Yield
dividend yield
Profit Margin
-34.3%
net profit margin
Gross Margin
78.1%
revenue minus COGS
ROE
-26.4%
return on equity
Beta
0.78
vs S&P 500
Price / Book
P/B ratio
52-Week Range
$73 — $147
annual min — max

EPS — Estimate vs Actual

Frequently Asked Questions

Is GKOS a good stock to buy right now?
Glaukos Corporation's Q·Score is 5.8/10 (Neutral), reflecting its current fundamentals, analyst data, and valuation metrics. Clean balance sheet with low leverage (0.2× debt-to-equity). Key area to monitor: currently unprofitable (-34% margin). This is an informational data summary only and does not constitute financial advice. Always do your own research before making any investment decision.
What is the analyst price target for GKOS?
The consensus price target for GKOS is $147.58, based on ratings from 12 Wall Street analysts. This is 5.3% above the current price of $140.22. Price targets are forward-looking estimates and not guarantees of future performance.
Is GKOS overvalued or undervalued?
Glaukos Corporation (GKOS) scores below peers on valuation metrics, trading above typical sector multiples. Its forward P/E ratio stands at 293.1×. The consensus analyst price target of $147.58 is 5% above the current price.
When does Glaukos Corporation report its next earnings?
Glaukos Corporation's next earnings report is expected on approximately July 29, 2026.
What is Glaukos Corporation's profit margin?
Glaukos Corporation has a net profit margin of -34.3%, indicating the company is currently operating at a net loss. Its gross margin stands at 78.1%, indicating a high-margin business model.
Is Glaukos Corporation's revenue growing?
Glaukos Corporation is reporting strong year-over-year growth of 41.2%.
How much debt does Glaukos Corporation have?
Glaukos Corporation has a debt-to-equity ratio of 0.16×, reflecting a very low debt-to-equity ratio, signalling a conservatively financed balance sheet. Its current ratio is 5.43×, indicating comfortable short-term liquidity.